Jupiter Topco’s AnaptysBio ANAB Stock Holding History

Jupiter Topco’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$504K	Buy	+7,464	New	+$452K	﹤0.01%	2094

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Jupiter Topco's ANAB Position: Q2 2026 in Review

Jupiter Topco opened a new position in AnaptysBio (ANAB) in Q2 2026: 7,464 shares worth $504K. The stake represents ﹤0.01% of the portfolio and ranks #2094 among its holdings.

191 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

Jupiter Topco held 7,464 shares of AnaptysBio worth $504K as of Q2 2026.
AnaptysBio was a new Jupiter Topco position in Q2 2026.
AnaptysBio made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #2094 holding.
191 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.